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The great epidemiological signiﬁcance and costs associated with chronic heart failure pose a challenge to health systems in Western
industrialcountries.Inthepastfewyears,controlledrandomisedstudieshaveshownthatpatientswithchronicheartfailurebeneﬁt
from telemedical monitoring; speciﬁcally, telemonitoring of various vital parameters combined with a review of the symptoms,
drug compliance and patient education. In Germany, various telemedical monitoring projects for patients with chronic heart
failure have been initiated in the past few years; seven of them are presented here. Currently 7220 patients are being monitored in
thesevenselectedprojects.Mostpatients(51.1%)areinNYHAstageII,26.3%inNYHAstageIII,14.5%inNYHAstageIandonly
6.6% in NYHA stage IV respectively. Most projects are primarily regional. Their structure of telemedical monitoring tends to be
modular and uses stratiﬁcation according to the NYHA stages. All projects include medical or health economics assessments. The
future of telemedical monitoring projects for patients with chronic heart failure will depend on the outcome of these assessments.
Only of there is statistical evidence for medical beneﬁt to the individual patient as well as cost savings will these projects continue.
1.Introduction
In the Western industrial nations, chronic heart failure has
great epidemiological signiﬁcance due to the rising number
of patients, particularly elderly ones [1]. This develop-
ment occurs in addition to the demographic development
characterised by low birth rates and an increasingly large
proportion of old and very old people. According to the
NewYorkHeartAssociation(NYHA)stage,theprognosisfor
chronic heart failure is in some cases worse than for various
malignant diseases [2].
Due to both, drug therapy (e.g., angiotensin-converting
enzyme blockers, AT1-receptor blockers, aldosterone antag-
onists, or beta-receptor blockers) and medical devices (e.g.,
implantable cardioverter-deﬁbrillators—ICD—and biven-
tricular stimulation), the prognosis for chronic heart failure
has improved in the past few years [3–5]. Therefore, these
component of therapy have been incorporated into the
guidelines of national and international specialist societies
on the treatment of chronic heart failure [6, 7]. However,
incorporating these recommendations, especially optimised
drug treatment, into clinical practice has been unsatisfactory
[5]. It has been shown that with targeted patient information
and education, medication adherence and therefore medical
outcomes of patients with chronic heart failure can be
improved [8–10].
One of the primary goals of the treatment of patients
with chronic heart failure is to avoid rehospitalisation.
The number and duration of rehospitalisations due to
decompensation of preexisting heart failure are not only of
serious impact the patients quality of life, but also pose a
large health-economic burden on the health system [11, 12].2 International Journal of Telemedicine and Applications
The cost for in-patient treatment of patients with chronic
heart failure in Germany amounted to 1.7 billion Euros in
2006. This corresponds to about 60% of the overall costs of
therapy for heart failure [12].
Thus, the primary goal must be to avoid or shorten
renewed and prolonged rehospitalisations. Disease man-
agement programmes can reduce the mortality and rate
of rehospitalisations and improve the quality of life of
patients with chronic heart failure [13, 14]. In this context,
questions arise regarding the options and eﬃciency oﬀered
by telemedical monitoring of patients with chronic heart
failure. The deﬁnition of telemedical applications in this
ﬁeld is not uniform. The scenarios range from telephone
support (nurse calls) and the monitoring of symptoms and
compliance, to a complex kind of telemedical monitoring
using automated transmission of data from medical devices
[15–17]. The system used in the European Network Home
Care Management System (TEN-HMS) study can now be
considered the “classic scenario” for telemedical monitoring
of patients with chronic heart failure [18]. This scenario is
presented in a modiﬁed form in Figure 1.
In addition to the patients and the medical service
providers (general practitioner, cardiologist in private prac-
tice, hospital), the most important partner in a complex
telemonitoring system is the telemedical service centre. All
data is collected here and integrated into the electronic
patient records and constitutes the central core of case
management.Thepatientstransmitvariousvitalparameters,
either at intervals or continuously, to the telemedical service
centre. The transmission of the vital parameters can be
conducted via telephone or mobile phone. In Germany,
one limiting factor seems to be the missing internet access,
particularly in primary care practices.
The relevant monitoring parameters are heart rate,
ECG (arrhythmias), blood pressure, and body weight. For
instance, it was shown in a clinical study that atrial ﬁb-
rillation worsens the prognosis for patients with chronic
heart failure [19]. Body weight monitoring is an important
clinical parameter in recognising cardiac decompensation.
By regularly monitoring body weight, mortality was signif-
icantly reduced in the Weight Monitoring in Heart Failure
(WHARF) trial [20]. An increase in body weight after release
from hospital is an important predictor of rehospitalisation
[21]. In addition, data from cardiac pacemakers, ICDs, or
systems for cardiac resynchronisation (biventricular cardiac
pacemakers or ICDs) are transmitted by remote control. The
telemedical service centre monitors and selects the data. The
data are then transmitted to the general practitioner, cardi-
ologist, or hospital, as needed. The individual partners have
access to the electronic patient records in accordance with
the rules of data protection and with protected passwords.
In addition, patients get contacted directly via telephone
from the telemedical service centre. During these calls,
questions can be asked about symptoms (edema, shortness
of breath, etc.) and the medication taken. Furthermore,
consultations and structured systematic training sessions
on various problems related to heart failure are oﬀered to
patients. Thanks to a round-the-clock presence of doctors in
the telemedical centre, it is possible to manage emergencies.
In the past few years, much international experience has
been gathered in this regard on telemonitoring in patients
with chronic heart failure, also in the context of randomised
controlled studies. In the following, we report on selected
projects in Germany.
2. Presentationof IndividualProjects
The German health system has traditionally been structured
according to sector, namely, the outpatient and inpatient
sectors.Governmentpolicyhasmadevariousattemptsinthe
last few years to overcome this division to some extent. One
important mean to achieve this is contracts for integrated
care [22].
In the past few years, a number of, mostly regional,
modelprojectsontelemonitoringpatientswithchronicheart
f a i l u r eh a v eb e e nc o n d u c t e di nG e r m a n y .T h e s ep r o j e c t s
brought forth signs of cooperation between the hospitals
and practising physicians, as the providers of medical care,
and various health insurance organisations. In addition,
providersoftelemedicalservicesandindustrialpartnerswere
included in the cooperation. Table 1 provides an overview of
selected telemedical projects for patients with chronic heart
failure in Germany.
Currently 7220 patients are being monitored in seven
selected telemonitoring projects for patients with chronic
heart failure. Most patients (51.1%) are in NYHA stage II,
26.3% in NYHA stage III, 14.5% in NYHA stage I, only
6.6% of patients were in NYHA stage IV, and in 1.6% of the
Patients the NYHA stage was unknown.
The selected projects are presented in greater detail in the
following sections.
2.1. “HeiTel”. The telemedical care of patients with heart
failure in the context of the HeiTel project makes it possible,
through monitoring, to institute and adjust therapy opti-
mised for the individual patient. The patient transmits by
telephone certain prescribed vital parameters (e.g., weight,
blood pressure) via modem to the telemedical centre in
an automated manner. If individually deﬁned threshold
values are not reached or exceeded, an alarm is immediately
triggered in the monitoring centre so that therapeutic
measures can be started immediately. Independent of any
alarmresponses,apatientinNYHAstagesIII-IViscontacted
proactively at least once a week, while a stage II patient is
contacted at least twice a month; they are asked questions
according to a standardised form. The goal of these contacts
is to promote medication adherence and to recognize telltale
changes in a patient’s health status as early as possible.
Patients can reach the telemedical centre around the clock
every day of the year to report cardiopulmonary symptoms
and serious complaints. Training sessions on nutrition,
movement and pharmacotherapy complete the programme
and reinforce the patient’s self-reliance in dealing with
himself and his illness.
After hospitalisation or after the conclusion of the
individual titration phase during the initiation of drug
therapy, which generally lasts about 6 months, there is a
de-escalation of the device-based home monitoring, as partInternational Journal of Telemedicine and Applications 3
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Figure 1: Overview of a complex telemedical support system for patients with chronic heart failure.
of a modular plan, which then becomes care provision by
means of training sessions on nutrition, movement and
monitoring of pharmacotherapy using a nurse call system.
The purpose of this is to reinforce the patient’s self-reliance
in coping with himself and his illness and to perpetuate the
success of treatment.
This modular plan oﬀers the opportunity of establishing
telemedical care as a cost-eﬃc i e n tm o d u l et h a ti si n t e g r a t e d
into a chain of medical services. More than 200 general prac-
titioners andcardiologists arecurrentlyactivelyparticipating
in this plan.
Theaccompanyingevaluationoftheprojectdocumented
a high-level of satisfaction among the participants. It more-
over, also demonstrated the plan’s eﬃciency in terms of
health economics by means of a signiﬁcant reduction both in
the overall costs and in the number of days of hospitalisation
for the HeiTel patients (n = 210) in comparison to a control
group (n = 12000) over a period of 2 years. This justiﬁes
the assumption that the intervention has a lasting eﬀect.
Although the plan was only designed for 12 months, these
results led to an extension of the contract for integrated
care.
2.2. The Telemedicine Centre Brandenburg (TMZB). The
Telemedicine Centre Brandenburg (Telemedizin Zentrum
Brandenburg, tmzb) was established in 2004 by the Munic-
ipal Hospital Brandenburg in Brandenburg/Havel. Its aim
is to improve the care for chronic cardiac patients in the
federal state of Brandenburg. In cooperation with getemed, a
medical technology company, and with funding by the Euro-
pean Union and by the Ministry of Economics of the state
of Brandenburg a telemonitoring unit was developed which
daily records and transmits all noninvasively parameters and
information regarding clinical symptoms, drug compliance,
and desired contact.
The promising results of a self-ﬁnanced pilot study led
to a contract with the AOK Brandenburg (a state-licensed
health insurance company) for integrated medical care for
patients with chronic heart failure.
Cooperations with various hospitals were established,
including the German Heart Centre in Berlin, and numerous
hospitals in the state of Brandenburg, as well as consulting
cardiologists and general practitioners. The telemedical
monitoring allows surveillance of patients from far distance,
which is advantageous in a large, sparsely populated state
with a low density of physicians.
Inclusion criteria are chronic heart failure NYHA stages
III-IV, an ejection fraction ≤40%, and a history of hos-
pitalization for acute decompensated heart failure. At the
moment, 300 patients of NYHA stages III and IV participate
in the program.
The patients receive a telemonitoring device, developed
by getemed, Teltow, a scale, ECG electrodes, and a blood
pressure gauge. The patient daily measures weight, blood
pressure, ECG, thorax impedance and breathing rate, and
for certain indications also oxygen saturation. Patients also
provide information regarding the severity of dyspnea, their
subjective well-being, medication intake, and preference
regarding desired personal contact. The data is encoded and
transmitted by internet to the TMBZ, where it is analysed
weekdays with regard to newly manifested arrhythmias,
heart rate, body weight, and blood pressure using individ-
ually determined threshold values, breathing rate, and, if
indicated, the oxygen saturation. The patient’s subjective
comments regarding dyspnea, peripheral edema, well-being,
and drug compliance are evaluated to detect worsening
symptoms.
If deterioration has been detected, the patient’s physician
is informed by fax or, in urgent cases, via telephone by
the tmzb. A summary of the reported results is included.
This objective data enables better adjustment of the patient’s
medication according to individually changing health status.
The patient is contacted by the tmzb if: (i) suspicious
changesofparametersarerecorded,(ii)thepatientrequested6 International Journal of Telemedicine and Applications
contact, (iii) no data was transmitted, or (iv) the preceding
intervention was not successful.
The closer collaboration between the individual patients
and their individual care givers (patient, general practitioner,
cardiologist, hospital, telemedical centre) allows for an opti-
mal care. The acceptance of telemonitoring among patients
is very high, as indicated by the fact that the compliance with
data transfer is 95%. Patients indicate that they feel secure.
No serious technical problems have been encountered.
Preliminary analyses of the data show a signiﬁcant reduction
both in number and days of hospitalisations for acutely
decompensated heart failure [23].
2.3. “CorBene”. The “CorBene” project was developed as
a contract for providing integrated care between prac-
ticing cardiologists, the Ford and Rhineland company
health insurance programme, and the companies Vitaphone
(Mannheim) and Medtronic (D¨ usseldorf). The goal is a
transsectoral, stage-speciﬁc therapy of patients with chronic
heartfailurethatisbasedontelemonitoringandisconducted
according to guidelines. The participating doctors proﬁt
fromauniformdocumentation,improvedexchangeofinfor-
mation, and integrated quality management. This prevents,
for example, redundant examinations. The telemedical con-
cept of monitoring consists of four modules. This guarantees
that the telemonitoring is appropriate to the NYHA stage
and is individual. In module 1, the patient is given an
ECG monitoring card to record his heart frequency and
detect cardiac arrhythmias. Module 2 consists of weight
monitoring. ECG and weight monitoring are linked together
in modules 3 and 4. All reported data is integrated into an
electronic patient record by the telemedical service centre
Vitaphone, which is certiﬁed according to ISO and the Asso-
ciation for Engineering/Electronics/Information Technology
(VDE) rules of application for telemonitoring [23, 24]. In
addition, the staﬀ of the telemedical service centre contacts
the patient by telephone regularly, on a daily basis if needed.
Theyenquireaboutsymptomsthatsuggestimminentcardiac
decompensation.Thereisalsoareminderfunctionfortaking
medication. Emergency management, including alerting the
rescue services, is provided, made possible by the round-the-
clock presence of physicians at the telemedical centre.
The “CorBene” project is being evaluated in terms of
health economics. Initial data from 306 patients show that
81.2%ofthepatientsincludedintheprojectarebeingtreated
according to the guidelines. 10.8% of these patients show
clearimprovementofclinicalsymptomssincetheyhavebeen
included in the project [25]. The ﬁnal results of the health
economics evaluation of the project are not yet available.
In the meantime, “CorBene”, which initially was a
regional project, has been extended to cover all of North
RhineWestphalia(NRW)andSaarland.Currentlymorethan
2900 patients with chronic heart failure are monitored by the
project.
2.4. “Telemedicine for the Heart”. Integrated concepts of
providing medical care that utilize telemedicine have been
proven to be appropriate instruments for improving current
deﬁcits for patients with cardiac failure. For this reason the
Techniker Krankenkasse health insurance company and the
German Foundation for the Chronically Ill developed the
integrated programme of medical care called “Telemedicine
for the Heart”. Patients from throughout Germany with
NYHA stages II-IV who are insured with the Techniker
Krankenkasse have proﬁted from this programme since
January 1st, 2006.
The modularly structured programme for providing
care, collecting data, interpreting data and training patients
allows the participants to deal with their illness in a safer
more self-empowered manner. It is also an important
adjuvant to the treatment provided by their physicians. The
goal of the patient-centred programme is to help the partic-
ipating patients gain patient empowerment, to understand
their illness better, to make the inﬂuencing factors between
chronic heart failure, the prescribed medicine and their own
lifestylemoretransparent.Italsoincreasespatientawareness
of warning signs and symptoms, that indicate imminent
decompensation. The analysis of life style with reference to
the patient’s own health situation encourages participants
to reduce risk factors and expand health-promoting factors.
By means of close coordination with the locally responsible
physician, the programme aims to reduce the frequency and
length of inpatient hospitalisations, at decreasing mortality,
and at oﬀering participants coordinated and high-quality
medical care [26].
The programme is set to run for 27 months, which are
divided into three phases. The ﬁrst 6-month is the training
phase. It familiarises the patients with the procedures of
the programme and, by means of telephone-based training,
provides speciﬁc knowledge about the complex topics asso-
ciated with chronic heart failure. The second phase is the
3-month stabilisation phase. It promotes a consolidation of
the behavioural patterns taught during the ﬁrst phase and
attempts to teach how to deal with the illness independently
on a daily basis. The third phase consists of an 18-month
refresher phase, aiming to anchor the behavioural patterns
that promote better health in daily routines of participating
patients, through constant repetition. This should allow,
the results that have been achieved to be maintained after
the participants have left the programme. The care and
training given to patients is provided by a telemedical
servicecentre(inthisprogramme,Vitaphone).Anelectronic
record is maintained for each patient at the telemedical
service centre. For patients in NYHA stages III and IV,
telemedical monitoring of body weight, blood pressure, and
the pulse is also planned. During the programme, necessary
interventionsaremadebythetelemedicalservicecentreteam
in coordination with the general practitioners and/or the
cardiologists if a threshold is crossed.
In the context of a health economics evaluation con-
ducted by the chair of health management at the University
of Erlangen-Nuremberg, the data of 281 participants in the
programme “Telemedicine for the Heart” (treatment group)
were compared to the data of a matched control group that
was three times larger in size. Examination of the number
of hospitalisations per patient and year, showed that for
the participants in the programme there were 21.5% fewer
hospitalisations (P = .03, t-test). This means that it wasInternational Journal of Telemedicine and Applications 7
possible to avoid approximately every ﬁfth hospitalisation
as the result of this intervention (i) an improved level of
knowledge among the participating patients, (ii) an early
warning function of the telemedical monitoring, and (iii)
close coordination between the telemedical centre and the
responsible physicians.
The evaluation also provides a clearly positive result with
regard to mortality. In the group of programme participants,
there was a 51.7% (P = .01, chi-squared test) reduction in
mortality within the ﬁrst year, that is, that with the most
intensive training and support phases. Even if the analysis
is extended to the maximum period of time (including the
last phase of the programme with a low intensity of care
provision), the mortality was reduced by 35.1% (P = .04,
chi-squared test), a value more than one third lower than the
mortality in the comparison group.
In the context of the evaluation, it could be shown that
the programme participants had a uniformly higher supply
rate of heart-speciﬁc medication. The training sessions
focused on heart failure and the communication optimised
within the integrated care context met the programme’s goal
of promoting the prescription of diagnosis and guideline
speciﬁc drugs.
The medical eﬀects reported above were achieved in
a cost-eﬃcient manner, as is shown by the overall costs.
There are substantial diﬀerences in favour of the treatment
group, both after 1 year of programme membership (savings
of 1592.16C, 18.1% of the total costs) as well as over the
maximum period of time observed normalised per year
(savings of 2633.40C, 25.0% of the total costs). These data
make it clear that the complete 27-month programme fully
paid for itself in its ﬁrst year of work, while the eﬀects
of the care provision—especially the eﬀect of the training
sessions—were maintained over a much longer period of
time.
In summary, the evaluation showed that the optimised
interplay of therapeutic supervision by the local physician
with the supportive care and training sessions provided by
“Telemedicine for the Heart” oﬀers an important contribu-
tion to stabilising patients’ health status. This programme is
able to train the participants in a cost-eﬃcient manner. They
learn to deal with their illness and to recognise imminent
decompensation early, especially if using speciﬁc telemedical
technology and the close coordination with their physicians.
This allows for the adjustment of therapy even on an
outpatient basis, lowering mortality, and avoiding repeated
and cost-intensive hospitalisations.
2.5. “Partnership for the Heart”. The research and develop-
ment project “Partnership for the Heart” is jointly sponsored
by the Charit´ e, University of Medicine Berlin, the Robert
Bosch Hospital in Stuttgart, and three industrial partners.
This project receives support from the government agency
for economics and technology.
The aim of the project is to establish a sensor platform
for patients, an electronic record for patients, as well as a
telemedical centre [27]. The sensor platform is a wireless
network (local area network) in the patient’s home. Various
sensors (for measuring blood pressure, a three-channel
ECG, weighing scales, and an activity sensor) are integrated
into this network. The sensors are connected wirelessly
via Bluetooth to a PDA that is part of a mobile phone
network. The measured data is ultimately transferred to the
telemedical center via the PDA. At the telemedical center,
the data is integrated into the patient’s electronic record.
The telemedical centres are directly attached to the hospitals
(Charit´ e Berlin, and Robert Bosch Hospital in Stuttgart) and
are staﬀed by physicians and caregivers. The staﬀ also has
the contact data of the patients’ general practitioners and
specialists and the phone numbers of the regional emergency
services [27].
The Partnership for the Heart study has examined a
total of 710 patients since January 2008. It is a multicentric
randomised prospective study of patients with chronic heart
failure that uses an open and controlled design (telemedical
participants and a control group) and follows patients for a
period of at least 12 months. In the telemedical group, there
is daily monitoring of blood pressure, ECG, oxygen satura-
tion, and body weight. Furthermore the patients’ physical
activity is evaluated by an activity sensor and the patient
himself evaluates his own health status. The study is ﬁnanced
and supported logistically by the Barmer and Bosch health
insurance companies. The primary end point of the study
is the period of survival. Secondary end points of the study
are overall mortality, cardiovascular mortality, frequency
of any kind of nonelective hospitalisation, frequency of
hospitalisations for cardiovascular reasons, the plasma level
of NT-proBNP over time and the quality of life over time,
An evaluation from the perspective of health economics is
planned [27, 28].
2.6. “HeartAs/HerzAs”. The project “HeartAs” was estab-
lishedincombinationwithanintegrated-carecontract.Until
now, 516 patients have been included in the project, 96 of
which have already concluded the program. The majority of
patients are in NYHA stage II and III. In this project, body
weight, ECG (12-channel or 1-channel), pulse, and blood
pressure are transmitted. The project consists of a modular
character. In addition to compliance management and
emergency management modules, regular telephoneadvice
calls are given. A medical, academic, and economic (cost
beneﬁt analysis) evaluation will follow.
2.7. “ProHeart/Herzensgut”. Some initial experience regard-
ingthetelemedicalmonitoringofpatientswithchronicheart
failure has been gathered in a project organised by the health
insurance company “Kaufm¨ annische Krankenkasse” and the
Almeda company in Munich. The idea behind this project
was similar to that of the ProHeart project. Participants
were contacted regularly by telephone by specially trained
medical personnel. On the one hand, the use of specially
developed software meant that the telephone conversations
were very standardized, while on the other, there was always
an opportunity to discuss the patient’s situation in detail in
an individual and problem-oriented manner. The telephone
contacts were supplemented by written training material
[29]. There was, in addition, telemetric monitoring of the
patient’s weight. Compared to a control group with 1838 International Journal of Telemedicine and Applications
patients, it was possible to lower the number of days in
hospital by 48% in the group of participants (214 patients).
An overall reduction in cost of 39.5% was achieved. The
evaluation was conducted in a stratiﬁed manner over a 1-
year period, while the observation period was in fact at least
6m o n t h sa n da tm o s t1 8[ 30].
During the observation period, 14.7% of the participat-
ing patients died, compared to 27.1% in the control group.
This diﬀerence was statistically signiﬁcant [30].
The project “ProHeart” is currently conducted by
Almeda company and the Allianz health insurance. Up to
now, 1545 patients in NYHA stages I–IV have been included
in the project
3. Discussion
The German projects on telemedical monitoring of patients
with chronic heart failure that are described individually
above exhibit diﬀerent approaches and plans for improving
the situation of these patients. Nonetheless, they share some
fundamental strategies. The goals are, besides monitoring
the patients’ status (weight, blood pressure, ECG), to remind
patientsoftheirmedication,tomonitorsymptomsindicative
of imminent cardiac decompensation, and to train patients
on topics relevant to heart failure. A signiﬁcant concern of
all the programmes is increasing the ability of the patients
themselves to manage their own illness. Most programmes
are planned for a limited time period. The timely limitations
of this program have to be discussed critically. Most of the
projects described were established and conducted within
the conﬁnes of integrated-care-contracts over a predeﬁned
frame of time. Undisputed is the fact that chronic heart
failure can improve only with consistent surveillance, for
which reason patients need further long-term monitoring.
This poses the question of which patients (NYHA stage)
derive the most beneﬁt from telemonitoring and which
intensity (daily, weekly...monitoring) should be adjusted
to individual patient needs. As a foundation, consistent
deﬁnition and measures of goals needs to be deﬁned
(mortality, rehospitalisation, quality-of-life). The discussed
projects demonstrate the heterogeneous of patients included
according to diﬀerences in NYHA stages.
In a meta-analysis of 14 randomised controlled studies
on telemonitoring of patients with heart failure, Clark
et al. demonstrated there was a 20% reduction in overall
mortality [17]. The eﬀect was greater in the telemonitoring
programmes than in the structured telephone. It is essential
to distinguish between the structured telephone support
and the telemonitoring programmes with transfer of vital
parameters (body weight, heart frequency, blood pressure,
ECG) [17].The eﬀects were greater in the telemonitoring
programmes than in the structured telephone support
programmes, although the diﬀerence was not statistically
signiﬁcant. Furthermore, the rate of rehospitalisation for
cardiac decompensation was reduced by 21%. Here, too,
there was no diﬀerence between the two groups [17].
Roth [31] and associates could demonstrate a reduction
of total hospital days of 66% with the usage of telemon-
itoring in patients with chronic heart failure, in the SHL
Telemedicine Projects. Most patients reported a signiﬁcant
improvement of their quality-of-life [31].
The results clearly show that telemonitoring and tele-
phone support programmes are beneﬁcial with regard to
mortality and the rehospitalisation rates for patients with
chronicheartfailure[15–17].Thecentralquestioncontinues
to be the nature of the intervention that the patient requires.
The results of the TEN-HMS study show that the results for
mortality and rehospitalisation were similar in both groups.
The programmes in the device-based telemedicine branch,
however,weremorecosteﬃcientthantheotherprogrammes
even after the system-related additional costs for the devices
were included, since it was possible to shorten the length
of in-patient treatment [18]. This makes a diﬀerentiated use
of telemedicine necessary for individual patients. The range
of items to be monitored should be selected according to
NYHA stage and be modular. For most patients in NYHA
stage II, a telephone support programme with monitor-
ing of symptoms, compliance management, training, and
facilitating self-observation appears to be suﬃcient in most
cases. Patients in NYHA stages III and IV would beneﬁt
more from telemonitoring with the additional daily transfer
of vital parameters. The telemedical monitoring software
should also have an individual character. In practice, this
means that only those parameters relevant for the individual
patient (e.g., body weight, blood pressure) are monitored.
At the patient’s end, these parameters are transmitted, for
instance, using Bluetooth via the individual devices (such as
weighing scales, blood pressure gauge) to a central patient
monitor. The patient monitor transmits the data on to the
telemedical service centre, generally via landline. Currently,
it depends on the telemedical provider involved which
of the diﬀerent hardware components are available. The
systems are not compatible with each other. This means
that a modular structure of heart failure programmes that
accords with the NYHA stages is an indicator of quality
in such programmes. In Table 2, the quality requirements
on telemedical monitoring programmes for patients with
chronic heart failure are summarized. In two current ran-
domised studies on telemonitoring [Home or Hospital in
Heart Failure (HHH) Study and Home Heart Failure (HF)
Study] could show evidence of a high degree of compliance
indatatransmissioneveninolderpatients[32,33].However,
the use of telemedical monitoring in the HHH Study was
unable to signiﬁcantly reduce the duration of in-patient
treatment for cardiac failure, cardiac death and hospitalisa-
t i o nd u et oh e a r tf a i l u r ei nc o m p a r i s o nt ou s u a lt r e a t m e n t .
Similar results were reported in the Home HF Study
[33].
The reasons discussed for this include the high level of
standard treatment for heart failure and intermittent data
transmission (once a week) [32]. The telemedical projects
conducted in Germany monitor a variety of vital parameters
(e.g., weight monitoring only or complex monitoring of
weight, ECG, blood pressure, pulsoximetry) and deﬁne
various monitoring intervals (daily or weekly). In order to
be able to compare the results, standardisation seems nec-
essary (choice of vital parameters to monitor, transmission
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Table 2: Quality requirements for telemedical support programmes for patients with chronic heart failure.
(i) Monitoring according to the NYHA stage
(ii) Ensuring treatment according to guidelines
(iii) Creating a modular system for individual telemedical monitoring
(iv) Standardizing telemedical monitoring (selection of vital parameters, transmission intervals, automatic data transfer)
(v) Integrating the recorded data in an electronic patient record
(vi) Networking between partners (general practitioner, cardiologist in private practice, hospital, rehabilitation facility)
(vii) Certiﬁcation of the telemedical service centre according to deﬁned standards
(viii) Establishing standardised operating procedures (SOPs) in telemedical service centres
(ix) Establishing an emergency management plan
(x) Contacting the patient directly by phone for reviewing symptoms, medication adherence, consultation
(xi) Enabling the patient to be self-reliant
(xii) Accompanying patient education with structured training programmes
(xiii) Accompanying medical and health-economic assessment
The electronic patient record is the central component
of telemedical patient monitoring. Recognising deviations
from established alarm thresholds allows both patients and
the treating physician (general practitioners, cardiologists)
to be alerted promptly. This permits close coordination
between the partners and early intervention in the patient.
In addition, personal telephone contact to the patient
is established through the telemedical service centre. By
means of this, enquiries can be made about symptoms and
complaints, it can be checked whether medication is being
taken, and patient education can be coordinated. The quality
of the telemedical care systems depends signiﬁcantly on the
work of the employees in the telemedical service centre. The
aim here must be to standardise procedures and certiﬁcation
of the telemedical service centres in the context of quality
assurance (Table 2). To this end, uniform standardized
operating procedures (SOPs) must be deﬁned and put
into practice. In Germany, telemedical support is provided
by specialized telemedical service centres. These may be
associated with individual Hospitals or be commercial
providers(i.e.,SHLTelemedicine,Vitaphone,orAlmeda).In
these telemedical service centers, specially trained personnel
contacts patients and physicians, monitors the vital signs,
and maintains the electronic patient record. The associ-
ation for Engineering/Electronics/Information Technology
e.V. (VDE) has established guidelines for telemonitoring and
certiﬁes telemedical service centers [24, 34]. This is the ﬁrst
step toward standardization and comparability of diﬀerent
programs.
Another essential concern in telemedical monitoring
is intercommunication between general practitioners, car-
diologists in private practice, hospitals and rehabilitation
facilities. This aspect is of great importance in Germany
since here there is traditionally a great division between out-
patient and inpatient sectors. Most telemedical monitoring
programmes were conducted for this reason in the context
of contracts for integrated care. In doing this, in addition
to physicians, medical insurance companies and telemedical
providers would be directly included in the projects.
The greatest challenge at the moment is the reim-
bursement of telemedical services. This applies both to the
service providers (physicians in private practice, hospitals)
and the telemedical providers. At the moment in Germany,
telemedicine for monitoring patients with chronic heart
failure is not a component of standard treatment. Thus
it can also be explained why most projects are regional
in character. In the next few years, it will be necessary
to more strongly develop the evidence of the beneﬁts of
telemedical monitoring in patients with heart failure. For
this, in addition to medical and economic evaluations
(mortality, rehospitalisation rates, therapy according to
guidelines, quality of life), health-economic evaluations are
also necessary. The programmes presented here have this
health-economic evaluation integrated into them as a ﬁxed
component of the programmes. Proof of the cost eﬃciency
of the programmes will be a crucial point for the future of
telemedical monitoring programmes. Currently, none of the
described projects have been completed, so that ﬁnal results
are not yet available.
4.SummaryandPerspective
In Germany, various projects on telemedical monitoring
of patients with chronic heart failure could have been set
up in the past few years. Most of these projects were
initiated in the context of contracts of integrated care and
are mostly regional in nature. The telemedical monitoring
programmesdiﬀerintermsoftheirchoiceofmonitoredvital
parameters, sequence and frequency of data transmission,
and duration. This makes a comparison only possible to
a limited extent. In addition, most of the programmes
are not yet completed, so that no ﬁnal assessment of
the medical-economic or health-economic evaluation is yet
possible. The further acceptance of patients and sponsors of
projects on telemedical monitoring of patients with chronic
heart failure will depend in the future on the evidence
for improvement of the medical variables (mortality, hos-
pitalisation rate, duration of hospital treatment) as well
as evidence of cost eﬃciency. Standardization is required
of the programmes for telemedical monitoring of patients
with chronic heart failure according to deﬁned quality
criteria.10 International Journal of Telemedicine and Applications
For the context of further studies some basic questions,
such as which patients (NYHA stage) derive the most beneﬁt
at which degree of intensity of telemonitoring, need to
be considered, in order to achieve lasting improvements
for these patients. In addition, attention need to be given
to the aﬀects of the physical separation of telemonitoring
on the doctor-patient relationship in order to increase the
physician’s and patient’s acceptance of telemonitoring.
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